Feature Channels: Vaccines

Filters close

Not for public release

This news release is embargoed until 27-Nov-2023 5:00 PM EST Released to reporters: 20-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Seven LJI scientists rank among
Released: 17-Nov-2023 2:05 PM EST
Seven LJI scientists rank among "Highly Cited Researchers"
La Jolla Institute for Immunology

Clarivate calls these scientists "pioneers," noting that ranking on the Highly Cited Researchers list is a sign that a scientist has published significant findings and influenced their field of study.

Released: 16-Nov-2023 3:05 AM EST
Fourth dose of COVID vaccine boosts protection in patients with rheumatic disease
Mass General Brigham

Patients with autoimmune rheumatic diseases, which include rheumatoid arthritis and other chronic disorders that cause inflammation, are at increased risk of SARS-CoV-2 infection, as well as death due to severe COVID-19.

Released: 15-Nov-2023 3:05 AM EST
Another step toward the HIV-1 vaccine: Dynamics of neutralizing antibodies
University of Cologne

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it produces these antibodies in vaccinated humans.

Newswise: Survey finds many Americans are letting their guard down during respiratory illness season
Released: 13-Nov-2023 9:05 AM EST
Survey finds many Americans are letting their guard down during respiratory illness season
Ohio State University Wexner Medical Center

Despite the Centers for Disease Control and Prevention warning this year will be potentially dangerous for respiratory illnesses, a third of Americans are not concerned about the threat, according to a new national survey by The Ohio State University Wexner Medical Center.

Released: 10-Nov-2023 4:05 PM EST
Is the US reporting system for vaccine safety broken?
BMJ

Investigation raises concerns that the system is not operating as intended and signals are being missed

Released: 10-Nov-2023 8:00 AM EST
Urgent Need for Increased Global Access to Effective Prevention and Treatment of Pneumonia
American Thoracic Society (ATS)

On World Pneumonia Day, Nov. 12, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is highlighting the urgent challenges in pneumonia prevention and treatment globally.

Newswise: Gender-neutral HPV vaccination best at preventing cervical cancer
Released: 8-Nov-2023 6:05 PM EST
Gender-neutral HPV vaccination best at preventing cervical cancer
Karolinska Institute

The most effective way to prevent cervical cancer is to give HPV vaccines to both boys and girls, reports a collaborative study involving researchers from Karolinska Institutet published in Cell, Host and Microbe. Beside personal immunity, such use of the vaccine also induces a herd immunity that will help to eradicate the carcinogenic virus types more quickly.

Released: 8-Nov-2023 5:05 PM EST
First evidence of how the Asian malaria mosquito is spreading drug-resistant malaria in Africa
Lancaster University

Asian malaria mosquito found to spread drug and diagnosis-resistant malaria in Africa.

Newswise: Flu Season Starting Late but Expected to Increase for the Holidays
Released: 7-Nov-2023 2:05 PM EST
Flu Season Starting Late but Expected to Increase for the Holidays
Vanderbilt University Medical Center

The current flu season has started later and more gradually than last year, according to William Schaffner, MD, professor of Preventive Medicine at Vanderbilt University Medical Center (VUMC), although cases are expected to begin increasing in November before falling off in March.

Released: 6-Nov-2023 6:05 PM EST
Learning more about how flu strains evolved may help guide future vaccine development – SFU research
Simon Fraser University

Simon Fraser University researchers studying the evolutionary history of flu viruses have found that a new quantitative analysis of how they evolved may help predict future strains.

Not for public release

This news release is embargoed until 30-Oct-2023 5:00 PM EDT Released to reporters: 24-Oct-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Oct-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 30-Oct-2023 1:00 PM EDT
Strategies Behind Near-Zero COVID-19 Incidence in NBA “Bubble” Published in ADLM’s The Journal of Applied Laboratory Medicine
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A report published today in the Association for Diagnostics & Laboratory Medicine’s (formerly AACC’s) The Journal of Applied Laboratory Medicine describes the strategies used by the National Basketball Association (NBA) to limit COVID-19 exposure among the individuals who participated in the 2019–2020 season. The success of the NBA’s approach demonstrates that strict adherence to certain protocols can be highly effective in preventing disease outbreaks in a self-contained environment and serves as a model for future pandemic management.

Released: 20-Oct-2023 9:00 AM EDT
Johns Hopkins Study Supports Potential for Injectable ‘Chemical Vaccine’ For Malaria Using Atovaquone
Johns Hopkins Bloomberg School of Public Health

Johns Hopkins researchers looking to develop a long-acting, injectable malaria preventive using atovaquone have shown in a new study that resistance may not be the challenge scientists thought it was, particularly when using atovaquone as a malaria preventive.

Newswise: UMass Amherst research finds adult vaccination rates increase when out-of-pocket costs decrease
Released: 18-Oct-2023 6:05 PM EDT
UMass Amherst research finds adult vaccination rates increase when out-of-pocket costs decrease
University of Massachusetts Amherst

Adults are more likely to follow government vaccination recommendations when they do not have to pay out of pocket for the vaccine, according to a new study by a University of Massachusetts Amherst researcher.

Released: 18-Oct-2023 5:05 PM EDT
Racing to defuse a ‘ticking’ public health time bomb
Yale University

The explosive rise in tick-borne diseases in many parts of the United States over the last five decades represents a major public health threat that demands innovative solutions, warns a group of Yale scientists.

16-Oct-2023 11:05 AM EDT
From One Nightmare to Another. Anthony Fauci’s New Concern
Georgetown University Medical Center

“What keeps you up at night?” It’s a question Anthony Fauci, MD, heard repeatedly over the course of his nearly four decades as director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. Today, as the COVID-19 pandemic wanes, Fauci describes a new nemesis – lack of “corporate memory.”

Released: 18-Oct-2023 5:05 AM EDT
Nanoparticle vaccine could curb cancer metastasis to lungs by targeting a protein
University of California San Diego

UC San Diego engineers have developed an experimental vaccine that could prevent the spread of metastatic cancers to the lungs. Its success lies in targeting a protein known to play a central role in cancer growth and spread, rather than targeting the primary tumor itself.

Newswise: News Tip: Johns Hopkins Medicine Experts Available for Interviews on Winter Respiratory Illnesses and Vaccines
Released: 17-Oct-2023 10:00 AM EDT
News Tip: Johns Hopkins Medicine Experts Available for Interviews on Winter Respiratory Illnesses and Vaccines
Johns Hopkins Medicine

The United States’ respiratory virus season — which typically lasts from October to April — is making its annual return. The flu, COVID-19, respiratory syncytial virus (RSV) infection and other respiratory illnesses tend to circulate more in the fall and winter months, which can lead to a surge in hospitalizations.

Released: 17-Oct-2023 9:05 AM EDT
Braidwood Management v Becerra Puts Over a Decade of Progress in Preventive Health Care At Risk
George Washington University

A brief filed on behalf of 111 public health and health law and policy Deans and Scholars, the American Public Health Association, the Robert Wood Johnson Foundation, Trust for America’s Health, and ChangeLab Solutions highlights new findings on the preventive health gains at stake in Braidwood Management v Becerra.

Released: 17-Oct-2023 9:00 AM EDT
CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing
Mount Sinai Health System

CastleVax, a clinical stage vaccine platform company, has received a Project NexGen award valued at up to $338 million from the Biomedical Advanced Research and Development Authority (BARDA), to support the development of a next-generation, booster vaccine to protect against COVID-19 for years to come.

Newswise: Scientists discover the possible triggers for bacterial pathogens, opening the door for new treatment strategies.
Released: 16-Oct-2023 5:05 PM EDT
Scientists discover the possible triggers for bacterial pathogens, opening the door for new treatment strategies.
University of Nevada, Las Vegas (UNLV)

A UNLV-led team studied potentially fatal, diarrhea-causing Shigella bacteria, and demonstrated a possible way to prevent it from causing disease.

Newswise: Directing vaccines to dendritic cells
Released: 16-Oct-2023 11:05 AM EDT
Directing vaccines to dendritic cells
National Institute of Biomedical Imaging and Bioengineering

Dendritic cells are key orchestrators of the immune response, but most vaccination strategies don’t effectively target them. NIBIB-funded researchers have developed biodegradable nanoparticles that are designed to deliver mRNA cargo to dendritic cells in the spleen.

Newswise: Vaccines: A few minutes now could spare you misery later
Released: 13-Oct-2023 8:05 AM EDT
Vaccines: A few minutes now could spare you misery later
Michigan Medicine - University of Michigan

A guide to vaccines that adults - especially older adults and those with underlying health issues - should get to avoid serious illness this fall and winter, and beyond.

Released: 12-Oct-2023 4:05 PM EDT
Jersey Shore University Medical Center Earns ACGME Accreditation for New Anesthesiology Residency Program
Hackensack Meridian Health

Hackensack Meridian Jersey Shore University Medical Center’s new four-year Anesthesiology Residency Program, launching spring 2024, recently earned accreditation from the Accreditation Council for Graduate Medical Education (ACGME).

Released: 11-Oct-2023 6:05 PM EDT
Pure capped mRNA vaccine opens the door to more effective vaccines with lower chances of inflammation
Nagoya University

A research group from Japan has developed a method to produce highly active mRNA vaccines at high purity using a unique cap to easily separate the desired capped mRNA.

Newswise: An AI Tool That Can Help Forecast Viral Outbreaks
10-Oct-2023 1:05 PM EDT
An AI Tool That Can Help Forecast Viral Outbreaks
Harvard Medical School

EVEscape predicts future viral mutations, new variants using evolutionary, biological information

Released: 10-Oct-2023 11:05 AM EDT
Statement on New Federal Guidance on the No Surprises Act from the American College of Emergency Physicians, American College of Radiology, American Society of Anesthesiologists, Emergency Department Practice Management Association
American Society of Anesthesiologists (ASA)

On Friday October 6th, the Centers for Medicare & Medicaid Services (CMS) announced new guidance in response to the August ruling in Texas Medical Association v. United States Department of Health and Human Services (“TMA III”) that vacated several provisions of the existing No Surprises Act (NSA) regulations.

Released: 9-Oct-2023 4:05 AM EDT
Vulnerability to different COVID-19 mutations depends on previous infections and vaccination, study suggests
University of Cambridge

A person’s immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure – and differences in the focus of immune responses will help scientists understand how to optimise vaccines in the future to provide broad protection.

Released: 6-Oct-2023 7:05 AM EDT
Vaccine via the nasal passage could be the new line of defence against Strep A
Griffith University

As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.

Released: 5-Oct-2023 9:30 AM EDT
Johns Hopkins Bloomberg School of Public Health Media Briefing on Preventing the Spread of Flu, COVID, and RSV This Fall
Johns Hopkins Bloomberg School of Public Health

The Johns Hopkins Bloomberg School of Public Health is hosting an expert briefing for the media from 2:00 p.m. to 2:30 p.m. EDT, Thursday, October 12, on how to take steps to stay healthy as COVID and RSV cases climb and flu season approaches.

Released: 4-Oct-2023 10:05 AM EDT
MSU expert: What to know about flu, RSV, new COVID-19 variant and new vaccine
Michigan State University

The new COVID-19 EG.5 variant is responsible for around 22% of current cases. The World Health Organization has classified it as a “variant of interest,” meaning countries should monitor it more closely than other strains — and cases have only increased in the past few weeks. Peter Gulick is an expert on infectious diseases, and he provides insight on what this new variant could mean and what you should know.

Newswise: The Medical Minute: Uptick in COVID cases, new vaccine available
Released: 4-Oct-2023 9:10 AM EDT
The Medical Minute: Uptick in COVID cases, new vaccine available
Penn State Health

Cases of COVID-19 are up since this summer, and a new vaccine is available. A Penn State Health infectious disease expert offers the latest on the pandemic.

Released: 3-Oct-2023 1:05 PM EDT
Why Flu Shots Are Important for Kids
Children's Hospital Los Angeles

If it’s autumn, then it must be influenza season, which means it’s time to consider flu shots for your family.

Newswise: New Nobel Prize in Medicine winner Katalin Karikó, launched career at USU
Released: 3-Oct-2023 11:05 AM EDT
New Nobel Prize in Medicine winner Katalin Karikó, launched career at USU
Uniformed Services University of the Health Sciences (USU)

A biochemist who got her start at the Uniformed Services University (USU), Dr. Katalin Karikó, was awarded the Nobel Prize in Medicine on Oct. 2 for her key discoveries that led to the development of the mRNA vaccines against COVID-19.

Released: 3-Oct-2023 6:05 AM EDT
Pharmacists can improve access to life-saving vaccines
University of Waterloo

HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer. Over 1,400 Canadian women are affected yearly, with almost 400 deaths, according to the Canadian Cancer Society.

Newswise: UM School of Medicine Researchers Present Interim Results on Meningococcal Vaccine for Infants and Young Children in Africa
Released: 2-Oct-2023 5:05 PM EDT
UM School of Medicine Researchers Present Interim Results on Meningococcal Vaccine for Infants and Young Children in Africa
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) researchers, as part of the Infectious Diseases Clinical Research Consortium (IDCRC), provided an interim analysis showing that the pentavalent (NmCV-5) meningitis vaccine is safe for use in 9-month-old infants in the meningitis belt of sub-Saharan Africa.

Released: 2-Oct-2023 4:05 PM EDT
Trivalent vaccine candidate fights measles, mumps, SARS-CoV-2
Ohio State University

Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests.

Newswise: APS Congratulates 2023 Nobel Laureates Katalin Karikó and Drew Weissman
Released: 2-Oct-2023 10:05 AM EDT
APS Congratulates 2023 Nobel Laureates Katalin Karikó and Drew Weissman
American Physiological Society (APS)

The American Physiological Society (APS) extends congratulations to Katalin Karikó, PhD, and Drew Weissman, MD, PhD, the 2023 recipients of the Nobel Prize in Physiology or Medicine.



close
2.55052